Nina Dominik

Jul 3, 2024 | onlinelibrary.wiley.com | Bernhard Scheiner |Nina Dominik |Mattias Mandorfer

We thank Dr. Kountouras et al. for their interest in our work.1, 2 As outlined in our recent study2 as well as previous work from our group,3 there is little clinical evidence suggesting that levels of coagulation proteins (neither VWF nor the factor VIII/protein C ratio) per se represent disease-driving mechanisms in chronic liver disease. Rather, these factors appear to reflect the natural course of disease as their levels are strongly correlated with liver disease severity.

May 25, 2024 | onlinelibrary.wiley.com | Nina Dominik |Georg Semmler |Lukas Hartl |Lorenz Balcar

We appreciate Prof Roccarina and Prof Ferraioli's thoughtful comments1 on our manuscript “The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy-controlled study”.

Mar 14, 2024 | onlinelibrary.wiley.com | Bernhard Scheiner |Alberto Zanetto |Lorenz Balcar |Nina Dominik

1 INTRODUCTION Von Willebrand factor (VWF) is released from endothelial cells upon activation and is usually significantly elevated in patients with advanced chronic liver disease (ACLD), in whom it is a highly versatile biomarker.